Last October, I joined a small group of biotech CEOs at the Laguna CEO Forum—an invite-only gathering hosted by Brook Byers of Kleiner Perkins. The setting? Montage Laguna Beach. Clifftop views, no press, no fluff—just serious biotech minds talking shop.
It was one of those rare events where people say what they actually think under Chatham House Rules. We dove deep into what’s broken in early-stage R&D, how AI is changing the game, and what the next decade of biotech could look like.
I was there repping Bioptic—and the belief that small teams with great AI can outpace Big Pharma. We’re building the tools to make that real. Screening 40 billion molecules in under three minutes. Designing molecules from scratch. Reimagining what drug discovery looks like when software takes the wheel.
Thanks to Brook and the Kleiner team for bringing this crew together. If you're building the future of biotech, or just curious how fast it's moving—follow along. We’ve got stories to tell.
–– Andrey
